Suggestions
Simone Schuerle
Assistant Professor (Tenure Track) at ETH Zurich
Simone Schuerle is an accomplished biomedical engineer and researcher currently serving as an Assistant Professor (Tenure Track) at ETH Zürich, where she heads the Responsive Biomedical Systems Lab.23 Born in 1985 in Ulm, Germany, Schuerle has made significant contributions to the fields of nanoengineering and microrobotics.5
Academic Background
Schuerle's academic journey includes:
- PhD in Mechanical Engineering from ETH Zürich (2009-2014)1
- Diplom (equivalent to M.Sc) in Industrial Engineering and Management from Karlsruhe Institute of Technology (2003-2009)1
- Undergraduate studies in nanomaterials at Kyoto University and biomedical engineering at the University of Canterbury1
Research Focus
At ETH Zürich, Schuerle's research concentrates on developing diagnostic and therapeutic systems at the nano- and microscale to address challenging medical problems.23 Her work spans several areas:
- Micro- and nanorobots for diagnostics
- Magnetically actuated systems for biomedical applications
- Tumor microenvironment characterization
- Drug delivery and transport enhancement
Career Highlights
- Postdoctoral research at MIT (2014-2017) on nanosensors for tumor profiling and drug transport enhancement24
- Co-founder of MagnebotiX, a spin-off company offering electromagnetic control systems for wireless micromanipulation24
- Recipient of several awards and fellowships, including the Prix Zonta for Women in Science (2019) and the Branco Weiss fellowship21
- Recognized as a "Young Scientist" by the World Economic Forum for her scientific contributions to society24
Professional Involvement
Schuerle serves on the Global Future Council on the Future of Human Enhancement for the World Economic Forum and is an Expert Advisory Board Member of the Singularity Group.5 She is also an advocate for women in STEM and promotes multidisciplinary approaches in scientific research.5
Simone Schuerle's innovative work in nanorobotics and magnetic servoing technologies continues to push the boundaries of biomedical engineering, with potential applications in personalized medicine and cancer treatment.35